A Bill for an Act
Page 1, Line 101Concerning appropriate state contracting with opioid
Page 1, Line 102antagonist businesses.
Bill Summary
(Note: This summary applies to this bill as introduced and does not reflect any amendments that may be subsequently adopted. If this bill passes third reading in the house of introduction, a bill summary that applies to the reengrossed version of this bill will be available at http://leg.colorado.gov.)
Under current law, the opioid antagonist bulk purchase fund (fund) allows the department of public health and environment (department) to bulk purchase opioid antagonists and distribute them to eligible entities.
In contracting for the bulk purchasing and distribution of opioid antagonists, the bill requires the department to contract with an opioid antagonist medication distributor. However, the bill prohibits the department from contracting with an opioid antagonist medication distributor if the distributor:
- Was found liable for the manufacture or distribution of an opioid that resulted in an opioid-related overdose;
- Is or was a liable party to a settlement agreement for the manufacture or distribution of an opioid that resulted in an opioid-related overdose; or
- Is or was liable for a fine or penalty levied by a governmental entity for the manufacture or distribution of an opioid that resulted in an opioid-related overdose.
The bill requires the department to implement a competitive selection process for the bulk purchase of opioid antagonists.
The bill declares any contract or agreement that does not comply with the contracting requirements of the bill is void and unenforceable.
Page 2, Line 1Be it enacted by the General Assembly of the State of Colorado:
Page 2, Line 2SECTION 1. In Colorado Revised Statutes, 25-1.5-115, amend (2) as follows:
Page 2, Line 325-1.5-115. Opioid antagonist bulk purchase fund - creation
Page 2, Line 4- report - rules - appropriation - definitions. (2) (a) Money in the fund
Page 2, Line 5is continuously appropriated to the department for bulk purchasing of
Page 2, Line 6opioid antagonists. Eligible entities may purchase opioid antagonists from
Page 2, Line 7the department. The department
may contract with a prescription drugPage 2, Line 8
outlet, as defined in section 12-280-103 (43), shall contract with anPage 2, Line 9opioid antagonist medication distributor for the bulk purchasing
Page 2, Line 10and distribution of opioid antagonists that are approved by the
Page 2, Line 11federal food and drug administration. The department may
Page 2, Line 12prioritize the purchase of opioid antagonists by eligible entities based on
Page 2, Line 13the need of the entity and the availability of the opioid antagonists as
Page 2, Line 14determined by the department. The department shall provide technical
Page 2, Line 15assistance to participating eligible entities to ensure that eligible entities
Page 2, Line 16complete all training and registration requirements.
Page 3, Line 1(b) (I) Notwithstanding subsection (2)(a) of this section,
Page 3, Line 2the department shall not enter into a contract for the bulk
Page 3, Line 3purchasing and distribution of opioid antagonists from an opioid antagonist medication distributor that:
Page 3, Line 4(A) Was found liable for the manufacture or distribution
Page 3, Line 5of an opioid that resulted in an opioid-related drug overdose event;
Page 3, Line 6(B) Is or was a liable party to a settlement agreement for
Page 3, Line 7the manufacture or distribution of an opioid that resulted in an opioid-related drug overdose event; or
Page 3, Line 8(C) Is or was liable for a fine or penalty levied by the
Page 3, Line 9federal government or a state or local government for the
Page 3, Line 10manufacture or distribution of an opioid that resulted in an opioid-related drug overdose event.
Page 3, Line 11(II) The department shall not enter into a contract for
Page 3, Line 12the bulk purchasing and distribution of opioid antagonists with
Page 3, Line 13an opioid antagonist medication distributor that is a division,
Page 3, Line 14subsidiary, parent, affiliate, or related entity under common
Page 3, Line 15ownership, control, or influence of an entity described pursuant to subsection (2)(b)(I) of this section.
Page 3, Line 16(c) (I) The department shall implement a competitive
Page 3, Line 17selection process subject to the "Procurement Code", articles
Page 3, Line 18101 to 112 of title 24, to select an opioid antagonist medication
Page 3, Line 19distributor or distributors for the bulk purchasing and
Page 3, Line 20distribution of opioid antagonists pursuant to this section. In
Page 3, Line 21the competitive selection process, the department shall state
Page 3, Line 22the prohibitions described pursuant to subsection (2)(b) of this
Page 4, Line 1section. To be eligible for a contract to sell and distribute
Page 4, Line 2opioid antagonists, the opioid antagonist medication distributor
Page 4, Line 3shall demonstrate, and the department shall verify, that the
Page 4, Line 4distributor is not prohibited pursuant to subsection (2)(b) of this section.
Page 4, Line 5(II) After the contract described pursuant to this
Page 4, Line 6subsection (2) is awarded, all selection process records are open
Page 4, Line 7to public inspection in accordance with the provisions of sections 24-72-203 and 24-72-204.
Page 4, Line 8(d) A contract or agreement that violates this subsection
Page 4, Line 9(2) is void and unenforceable as contrary to the public policy of the state.
Page 4, Line 10SECTION 2. Act subject to petition - effective date. This act
Page 4, Line 11takes effect at 12:01 a.m. on the day following the expiration of the
Page 4, Line 12ninety-day period after final adjournment of the general assembly; except
Page 4, Line 13that, if a referendum petition is filed pursuant to section 1 (3) of article V
Page 4, Line 14of the state constitution against this act or an item, section, or part of this
Page 4, Line 15act within such period, then the act, item, section, or part will not take
Page 4, Line 16effect unless approved by the people at the general election to be held in
Page 4, Line 17November 2026 and, in such case, will take effect on the date of the official declaration of the vote thereon by the governor.